IL299295A - Methods and compositions for treating hemophilia - Google Patents
Methods and compositions for treating hemophiliaInfo
- Publication number
- IL299295A IL299295A IL299295A IL29929522A IL299295A IL 299295 A IL299295 A IL 299295A IL 299295 A IL299295 A IL 299295A IL 29929522 A IL29929522 A IL 29929522A IL 299295 A IL299295 A IL 299295A
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- treating hemophilia
- hemophilia
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063042390P | 2020-06-22 | 2020-06-22 | |
| PCT/US2021/038445 WO2021262695A1 (en) | 2020-06-22 | 2021-06-22 | Methods and compositions for treating hemophilia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL299295A true IL299295A (en) | 2023-02-01 |
Family
ID=76943130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299295A IL299295A (en) | 2020-06-22 | 2022-12-20 | Methods and compositions for treating hemophilia |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20210393669A1 (https=) |
| EP (1) | EP4168018A1 (https=) |
| JP (1) | JP2023531679A (https=) |
| KR (1) | KR20230027277A (https=) |
| CN (1) | CN115942940A (https=) |
| AU (1) | AU2021296786A1 (https=) |
| BR (1) | BR112022026265A2 (https=) |
| CA (1) | CA3188137A1 (https=) |
| IL (1) | IL299295A (https=) |
| MX (1) | MX2023000164A (https=) |
| TW (1) | TW202216172A (https=) |
| WO (1) | WO2021262695A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240075001A1 (en) * | 2022-05-24 | 2024-03-07 | Darren Rubin | Methods to reduce hemorrhage and mortality on the battlefield and applications for trauma patients |
| US20240000744A1 (en) * | 2022-06-08 | 2024-01-04 | Genzyme Corporation | Treatment of Hemophilia with Fitusiran |
| CN118460655B (zh) * | 2024-07-10 | 2025-01-28 | 凯莱英医药集团（天津）股份有限公司 | 抑制FXI基因表达的siRNA的制备方法 |
| WO2026012399A1 (zh) * | 2024-07-10 | 2026-01-15 | 正大天晴药业集团股份有限公司 | 靶向serpinc1的双链核糖核酸 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9127274B2 (en) | 2012-04-26 | 2015-09-08 | Alnylam Pharmaceuticals, Inc. | Serpinc1 iRNA compositions and methods of use thereof |
| KR20180095843A (ko) | 2015-12-07 | 2018-08-28 | 젠자임 코포레이션 | Serpinc1-연관 장애의 치료를 위한 방법 및 조성물 |
| TW202434265A (zh) * | 2017-07-10 | 2024-09-01 | 美商健贊公司 | 於患有血友病之個體中治療出血事件之方法及組成物 |
-
2021
- 2021-06-22 CA CA3188137A patent/CA3188137A1/en active Pending
- 2021-06-22 JP JP2022578970A patent/JP2023531679A/ja active Pending
- 2021-06-22 MX MX2023000164A patent/MX2023000164A/es unknown
- 2021-06-22 WO PCT/US2021/038445 patent/WO2021262695A1/en not_active Ceased
- 2021-06-22 AU AU2021296786A patent/AU2021296786A1/en active Pending
- 2021-06-22 US US17/354,818 patent/US20210393669A1/en not_active Abandoned
- 2021-06-22 CN CN202180044790.1A patent/CN115942940A/zh active Pending
- 2021-06-22 TW TW110122791A patent/TW202216172A/zh unknown
- 2021-06-22 EP EP21742607.1A patent/EP4168018A1/en active Pending
- 2021-06-22 BR BR112022026265A patent/BR112022026265A2/pt unknown
- 2021-06-22 KR KR1020237002631A patent/KR20230027277A/ko active Pending
-
2022
- 2022-12-20 IL IL299295A patent/IL299295A/en unknown
-
2025
- 2025-09-17 US US19/331,354 patent/US20260014188A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021262695A1 (en) | 2021-12-30 |
| KR20230027277A (ko) | 2023-02-27 |
| BR112022026265A2 (pt) | 2023-01-17 |
| JP2023531679A (ja) | 2023-07-25 |
| MX2023000164A (es) | 2023-07-06 |
| TW202216172A (zh) | 2022-05-01 |
| AU2021296786A1 (en) | 2023-02-23 |
| CN115942940A (zh) | 2023-04-07 |
| CA3188137A1 (en) | 2021-12-30 |
| US20260014188A1 (en) | 2026-01-15 |
| US20210393669A1 (en) | 2021-12-23 |
| EP4168018A1 (en) | 2023-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL299295A (en) | Methods and compositions for treating hemophilia | |
| ZA202207394B (en) | Compositions and methods for treating hemoglobinopathies | |
| IL286350A (en) | Preparations and methods for the treatment of cancer | |
| IL288914A (en) | Preparations and methods for the treatment of cancer | |
| ZA202104870B (en) | Methods and compositions for treating cancer | |
| IL285886A (en) | Preparations and methods for the treatment of laminopathy | |
| IL285796A (en) | Methods and preparations for the treatment of cancer | |
| IL309296A (en) | Methods and compositions for the treatment of angiotensinogen-related disorder (AGT-) | |
| IL280413A (en) | Bismuth-thiol preparations and wound treatment methods | |
| IL287982A (en) | Preparations and methods for the treatment of cancer | |
| SG11202012055PA (en) | Methods and compositions for preventing or treating calciphylaxis | |
| EP4096675A4 (en) | COMPOSITIONS AND METHODS FOR TREATING LONG COVID | |
| IL304404A (en) | Compositions and methods for treating hereditary angioedema | |
| IL305806A (en) | Compounds and methods for the treatment of polycythemia | |
| IL286153A (en) | Methods and preparations for the treatment of cancer | |
| IL309120A (en) | Methods and compositions for the treatment of cancer | |
| IL309071A (en) | Methods and compositions for the treatment of cancer | |
| IL288440A (en) | Materials and methods for the treatment of retinopathy | |
| GB201913122D0 (en) | Compositions and methods for treatment of cholangiocarcinoma | |
| IL289086A (en) | Methods and preparations for the treatment of hemophilia and low mineral bone density | |
| IL312846A (en) | Methods and preparations for the treatment of cancer | |
| GB202314878D0 (en) | Methods and compositions for treating clostridiodes difficile infections | |
| IL307872A (en) | New compositions and methods for the treatment of corona virus infections | |
| IL306063A (en) | Preparations and methods for the treatment of neurological diseases | |
| IL285036A (en) | Methods and preparations for the treatment of cancer |